New radiation drug shows promise for kids with incurable brain tumors
NCT ID NCT05610891
First seen Apr 01, 2026 · Last updated Jun 10, 2026 · Updated 12 times
Summary
This study tests a new drug called CLR 131, a type of targeted radiotherapy, in children, teens, and young adults (ages 10-25) with a hard-to-treat brain cancer called high-grade glioma that has come back or not responded to treatment. The main goals are to find the safest dose and see if it can shrink tumors or slow the cancer's growth. About 50 participants will receive one of two dose levels, and doctors will monitor side effects and use MRI scans to measure response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH GRADE GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Stanford University
Palo Alto, California, 94304, United States
-
Texas Children's Cancer Center, Baylor College of Medicine
Houston, Texas, 77030, United States
-
UT Southwestern Medical Center
Dallas, Texas, 75390, United States
-
University of Wisconsin, Carbone Cancer Center
Madison, Wisconsin, 53705, United States
Conditions
Explore the condition pages connected to this study.